HEADER TRANSCRIPTION 24-JAN-16 5HRV TITLE CRYSTAL STRUCTURE OF THE FIFTH BROMODOMAIN OF HUMAN PB1 IN COMPLEX TITLE 2 WITH 1-ETHYLISOCHROMENO[3,4-C]PYRAZOL-5(2H)-ONE) COMPOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN POLYBROMO-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 613-734; COMPND 5 SYNONYM: HPB1,BRG1-ASSOCIATED FACTOR 180,BAF180,POLYBROMO-1D,PB1 COMPND 6 FIFTH BROMODOMAIN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PBRM1, BAF180, PB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS BRM1, BRG1-ASSOCIATED FACTOR 180, TRANSCRIPTION, CHROMATIN REMODELING EXPDTA X-RAY DIFFRACTION AUTHOR C.TALLANT,V.MYRIANTHOPOULOS,N.GABORIAUD-KOLAR,J.A.NEWMAN,S.PICAUD, AUTHOR 2 F.VON DELFT,C.H.ARROWSMITH,A.M.EDWARDS,C.BOUNTRA,E.MIKROS,S.KNAPP REVDAT 3 10-JAN-24 5HRV 1 REMARK REVDAT 2 26-OCT-16 5HRV 1 JRNL REVDAT 1 12-OCT-16 5HRV 0 JRNL AUTH V.MYRIANTHOPOULOS,N.GABORIAUD-KOLAR,C.TALLANT,M.L.HALL, JRNL AUTH 2 S.GRIGORIOU,P.M.BROWNLEE,O.FEDOROV,C.ROGERS,D.HEIDENREICH, JRNL AUTH 3 M.WANIOR,N.DROSOS,N.MEXIA,P.SAVITSKY,T.BAGRATUNI, JRNL AUTH 4 E.KASTRITIS,E.TERPOS,P.FILIPPAKOPOULOS,S.MULLER, JRNL AUTH 5 A.L.SKALTSOUNIS,J.A.DOWNS,S.KNAPP,E.MIKROS JRNL TITL DISCOVERY AND OPTIMIZATION OF A SELECTIVE LIGAND FOR THE JRNL TITL 2 SWITCH/SUCROSE NONFERMENTING-RELATED BROMODOMAINS OF JRNL TITL 3 POLYBROMO PROTEIN-1 BY THE USE OF VIRTUAL SCREENING AND JRNL TITL 4 HYDRATION ANALYSIS. JRNL REF J.MED.CHEM. V. 59 8787 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27617704 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00355 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0131 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 18059 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 941 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1213 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.02 REMARK 3 BIN R VALUE (WORKING SET) : 0.2580 REMARK 3 BIN FREE R VALUE SET COUNT : 54 REMARK 3 BIN FREE R VALUE : 0.3440 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 957 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.38000 REMARK 3 B22 (A**2) : -1.45000 REMARK 3 B33 (A**2) : 0.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.087 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.088 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.058 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.770 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1010 ; 0.017 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 977 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1358 ; 1.554 ; 2.013 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2255 ; 1.008 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 118 ; 5.087 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 49 ;31.809 ;23.673 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 202 ;12.175 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;12.942 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 143 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1104 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 224 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 463 ; 1.858 ; 2.323 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 462 ; 1.859 ; 2.316 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 578 ; 2.747 ; 3.462 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 579 ; 2.745 ; 3.471 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 547 ; 3.280 ; 2.764 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 548 ; 3.278 ; 2.762 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 779 ; 5.261 ; 3.940 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 1284 ; 7.036 ;19.311 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 1285 ; 7.033 ;19.311 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5HRV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000217627. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JAN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6-7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9796 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19011 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 28.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : 0.02300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 28.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3G0J REMARK 200 REMARK 200 REMARK: PLATE CRYSTALS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-SODIUM CITRATE DIHYDRATE PH REMARK 280 5.6, 20% ISOPROPANOL, 20% PEG4K, PH 7.5, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 20.77650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 20.77650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 28.90850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 70.13600 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 28.90850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 70.13600 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 20.77650 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 28.90850 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 70.13600 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 20.77650 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 28.90850 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 70.13600 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 643 REMARK 465 MET A 644 REMARK 465 SER A 645 REMARK 465 GLY A 646 REMARK 465 ILE A 647 REMARK 465 SER A 648 REMARK 465 PRO A 649 REMARK 465 LYS A 650 REMARK 465 LYS A 651 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG A 690 O HOH A 901 1.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 64C A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 802 DBREF 5HRV A 645 766 UNP Q86U86 PB1_HUMAN 613 734 SEQADV 5HRV SER A 643 UNP Q86U86 EXPRESSION TAG SEQADV 5HRV MET A 644 UNP Q86U86 EXPRESSION TAG SEQRES 1 A 124 SER MET SER GLY ILE SER PRO LYS LYS SER LYS TYR MET SEQRES 2 A 124 THR PRO MET GLN GLN LYS LEU ASN GLU VAL TYR GLU ALA SEQRES 3 A 124 VAL LYS ASN TYR THR ASP LYS ARG GLY ARG ARG LEU SER SEQRES 4 A 124 ALA ILE PHE LEU ARG LEU PRO SER ARG SER GLU LEU PRO SEQRES 5 A 124 ASP TYR TYR LEU THR ILE LYS LYS PRO MET ASP MET GLU SEQRES 6 A 124 LYS ILE ARG SER HIS MET MET ALA ASN LYS TYR GLN ASP SEQRES 7 A 124 ILE ASP SER MET VAL GLU ASP PHE VAL MET MET PHE ASN SEQRES 8 A 124 ASN ALA CYS THR TYR ASN GLU PRO GLU SER LEU ILE TYR SEQRES 9 A 124 LYS ASP ALA LEU VAL LEU HIS LYS VAL LEU LEU GLU THR SEQRES 10 A 124 ARG ARG ASP LEU GLU GLY ASP HET 64C A 801 16 HET EDO A 802 4 HETNAM 64C 1-ETHYLISOCHROMENO[3,4-C]PYRAZOL-5(3H)-ONE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 64C C12 H10 N2 O2 FORMUL 3 EDO C2 H6 O2 FORMUL 4 HOH *99(H2 O) HELIX 1 AA1 THR A 656 TYR A 672 1 17 HELIX 2 AA2 SER A 681 LEU A 685 5 5 HELIX 3 AA3 LEU A 693 ILE A 700 1 8 HELIX 4 AA4 ASP A 705 ALA A 715 1 11 HELIX 5 AA5 ASP A 720 ASN A 739 1 20 HELIX 6 AA6 SER A 743 LEU A 763 1 21 SITE 1 AC1 11 ILE A 683 PHE A 684 TYR A 696 MET A 704 SITE 2 AC1 11 ASP A 705 MET A 731 ALA A 735 TYR A 738 SITE 3 AC1 11 ASN A 739 HOH A 906 HOH A 944 SITE 1 AC2 6 ILE A 683 LEU A 744 ILE A 745 ASP A 748 SITE 2 AC2 6 HOH A 912 HOH A 927 CRYST1 57.817 140.272 41.553 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017296 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007129 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024066 0.00000